Daniella Hirons Email Address

Site Director, Clinical Operations

Odonate Therapeutics is dedicated to the development of therapeutics that improve and extend the lives of patients with cancer

THERAPEUTIC AREA EXPERIENCE: Phase II, III – Respiratory: Asthma, COPD Phase I, II, III – Metabolic Disease: Type 1 Diabetes, Type 2 Diabetes (including renal impairment), Nonalcoholic Steatohepatitis, Obesity and Weight Loss Phase II, III – Neurology: Psychiatric (Depression, Bipolar, Generalized Anxiety, Schizophrenia), Migraine (acute, prophylactic), Epilepsy/Seizure, Multiple Sclerosis, Parkinson’s, ADHD, Acute Ischemic Stroke, Secondary Stroke Prevention, Diabetic Neuropathy, Postherpatic Neuralgia Phase II, III – Immunology: Rheumatoid Arthritis, Psoriatic Arthritis, Transplant, Ulcerative Colitis, Crohn’s Disease, Irritable Bowel, Systemic Lupus Erythematous, Lupus Nephritis, Osteoarthritis Phase II, III – Cardiovascular: Hypertension, Atrial Fibrillation, Cyanotic Congenital Heart Disease, Anti-Flushing, Cardiovascular Risk, Atherosclerotic Plaque Inflammation Phase I, II, III – Infectious Disease: Hepatitis B, Hepatitis C, Herpes, Vaccine Phase I, II, III – Oncology: Breast, Endometrial, Ovarian, Prostate, Hematologic Malignancy (multiple myeloma, T-cell lymphoma, B-cell lymphoma, Hodgkins lymphoma, non-Hodgkins lymphoma, leukemia, acute myeloid leukemia, myelofibrosis), Renal Cell, Lung (small cell, non-small cell), Hepatocellular Phase I – Healthy Volunteer